More than 1500 persons in Norway have had a liver transplantation. But how can doctors know which patients need extra ...

Over 1500 people in Norway have had a liver transplantation. But how can doctors know which patients need extra follow-up or ...

This article explores how immune biomarkers can predict disease risk, guide treatment choices and overcome challenges to advance personalized medicine.

While it can help with early detection and targeted treatment for Alzheimer's disease, multiple sclerosis and more, it is particularly impactful for cancer patients. Timing is everything when it comes ...

Bladder cancer is a painful and often recurring disease, not just for humans, but for our canine companions as well. Urothelial carcinoma, the most common type of bladder cancer, affects both species ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

As tests and screenings for chronic conditions improve, Connecticut residents will have better access after lawmakers passed legislation mandating health insurance plans cover biomarker tests starting ...

TSPO levels rise early in Alzheimer’s and persist throughout disease. Targeting this biomarker could open new treatment options. TSPO, a major marker of brain inflammation, may offer a way to detect ...

Please provide your email address to receive an email when new articles are posted on . Acceptance and utilization of lung cancer biomarker testing has increased in the past 6 years, but key barriers ...

Discover how biomarkers like neurofilament light chain and glial fibrillary acidic protein enhance personalized care for ...

TSPO, a key biomarker of brain inflammation, could help detect Alzheimer's disease years before memory loss and other symptoms set in – potentially leading to advances in how the disease […] The post ...